Looking for leads, investment insights, or competitive intelligence?
News about Johnson & Johnson
Must-read business news, delivered every morning.
J&J will appeal the verdict, which it argues is "the product of a fundamentally unfair process."
The decision to sue is seen as an acknowledgment opioid makers won’t get serious about settling until the cases go to trial.
Mark Zuckerberg’s media tour is too little, too late.
The tech giant is stuck in a leadership crisis.